Message from the CEO

Message from the CEO

The Respiratory Institute opened in January 2015 to help patients with respiratory disease. Here are highlights from our first year.

The Institute brought together the renowned expertise of National Jewish Health in Denver, Colorado, and the Icahn School of Medicine at Mount Sinai. This collaboration created a New York City-based center focused on respiratory conditions. This partnership created a way to share knowledge and resources through a model of integrated collaboration. We successfully implemented that patient-centered, multi-disciplinary model in disease management, patient care, scientific research and professional education.

National Jewish Health is the nation’s leading respiratory hospital. It is also world renowned for its multidisciplinary team approach to patient care and expertise in COPD, asthma and bronchiectasis. Mount Sinai is a world leader in sarcoidosis, lung cancer, genetics/genomics, bioinformatics and biocomputational analysis. Combining the best of these two organizations brought unparalleled care for all respiratory conditions to New York.

The patient is at the center of clinical care at the Institute. Surrounding the patient is a team of physicians and allied health professionals from multiple disciplines including: pulmonology, rheumatology, thoracic surgery, immunology, radiology, cardiology, gastroenterology, otolaryngology, nursing, social work and rehabilitation. This integrated team works together to diagnose and treat patients. It also coordinates and tracks patients from intake through treatment follow-up for more efficient care.

This multidisciplinary approach moves beyond the standard in pulmonary care offered in most hospitals and medical practices. Collaboration among our specialists incorporates precision medicine, genomics, data-driven protocols and advanced diagnostic technology to enhance quality and outcomes. Our integrated coordination of care means patients have access to comprehensive and cohesive care at one location. Providers and patients also benefit from improved communications that result from working so closely together.

Included among the Respiratory Institute’s research endeavors last year is the development of two mobile apps. Our investigators partnered with scientists from the Icahn Institute for Genomics and Multiscale Biology and LifeMapp Inc. They developed two novel mobile health applications that provide monitoring and educational tools for patients with asthma and COPD. These apps will empower patients to better monitor and manage their conditions. Patients will now have nearly instant access to care teams when help is needed. Other areas of research in progress include: lung cancer, lung injury, sarcoidosis, interstitial lung disease, critical care informatics, pulmonary embolism risk and immunity in the lungs.

Early in 2015, we offered our first medical educational program for health care providers in the greater New York City area. The program shared best practices in idiopathic pulmonary fibrosis (IPF) and COPD care. This well-attended event helped educate, support and improve the lives of patients with IPF. Working with our partners at National Jewish Health, we look forward to bringing additional programs to our physician community.

Our first year has been successful. We look forward to 2016 bringing more innovations to our delivery of pulmonary care in New York for the benefit of our patients.

Charles Powell, MD
Professor, Pulmonary, Critical Care and Sleep Medicine Division, Icahn School of Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
CEO, Mount Sinai - National Jewish Health Respiratory Institute